Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.

Caregivers of individuals diagnosed with acute leukemia face a difficult balancing act: meeting the urgent demands of cancer ...

The deal hands Amgen a drug that destroys two proteins known to drive certain types of acute myeloid leukemia, a profile that ...

OXFORD, England, Jan. 6, 2026 /PRNewswire/ -- Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been ...

Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Decades ago, patients who were diagnosed with acute myeloid leukemia, a rare cancer of the bone marrow and blood, were told there was nothing doctors could do for them. In part due to pioneering ...